Home » News » Radboudumc and KNAW join the Netherlands Centre for One Health

Radboudumc and KNAW join the Netherlands Centre for One Health

Radboud University Medical Center (Radboudumc) and the Royal Netherlands Academy of Arts and Sciences (KNAW) have joined the Netherlands Centre for One Health (NCOH) as Partner as per 1 January 2018. NCOH unites experts from Utrecht University, University Medical Center Utrecht, Wageningen University and Research, Erasmus Medical Center Rotterdam, Academic Medical Center Amsterdam, Leiden University, and Leiden University Medical Center in the areas of human and animal health, thereby forming a strong academic network on infectious diseases in the Netherlands.

Infectious diseases have an increasingly large impact on the health of humans and animals worldwide, including densely-populated countries like the Netherlands. In 2050, about ten million people are predicted to die worldwide from antibiotic-resistant bacterial infections alone if we do not find new solutions, while viral infections are also spreading at an alarming rate. The four NCOH strategic research themes  focus on studying the interactions and connections between human, veterinary, wildlife, and environmental health in pursuit of durable solutions to the grand societal challenges requiring a One Health approach.

“To find new solutions to combat infectious diseases, like the issue of antimicrobial resistance, we need a holistic view and a multidisciplinary approach, which is an important reason for us to join NCOH”, says professor Heiman Wertheim, clinical microbiologist and chair of the Radboud Center of Infectious Diseases. “At Radboudumc we have a strong research theme on infectious diseases and global health with operational multidisciplinary research networks worldwide. Recently we recruited a PhD student as part of the NCOH collaboration who will work on fungal infections where antimicrobial resistance is a major, but often neglected, issue. We look forward to contribute to NCOH, learn from each other and conduct relevant research together.”

The Royal Netherlands Academy of Arts and Sciences (KNAW) will participate in NCOH through three of its institutes that are thematically linked to the NCOH Strategic Research Agenda: Westerdijk Fungal Biodiversity Institute, Hubrecht Institute for Developmental Biology & Stem Cell Research, and Netherlands Institute of Ecology (NIOO).

“With Radboudumc and the KNAW both joining the NCOH as a partner, the leading academic research institutes will now form an even stronger academic network on infectious diseases in the Netherlands. NCOH is indeed a joint scientific force further tackling One Health issues in public health, animal health, food production and the environment, with an integrated and interdisciplinary approach.”, says Martin Scholten, chairman of the NCOH Supervisory Board.

More News

Masterclass Globally prepared for future outbreaks of ‘Disease X’

Leading scientists Jeremy Farrar, Marion Koopmans, and Ron Fouchier will take you into the world of new infectious diseases outbreaks and show you how we can prepare for these outbreaks.

More

Why do people who live near goat farms have a higher chance of developing pneumonia?

People who live in the vicinity of a goat farm have a higher chance of developing pneumonia. That was demonstrated by the study “Livestock farming and the health of neighbouring residents (VGO)”, which was carried out in Oost-Brabant and Noord-Limburg. The possible causes of this are still not known. On behalf of the Ministry of...

More

NCOH participates in the EU-funded project One Health European Joint Programme (One Health EJP)

NCOH Partners are involved in a recently-granted One Health European Joint Programme, which started last January. In the One Health EJP, 39 partners from 19 EU member states are gathered to create a sustainable European One Health framework by integration and alignment of medical, veterinary and food institutes through joint programming of research agendas matching...

More

COMBACTE – 5 YEARS IN

Antimicrobial resistance (AMR) is a growing problem worldwide, and with few new drugs making it to the market, there is an urgent need for new medicines to treat resistant infections. The COMBACTE (COMBatting AntimiCrobial resisTance in Europe) project aims to give antibiotic drug development a much-needed boost by pioneering new ways of designing and implementing...

More